New Horizons in Prostate Cancer Treatment: Nanomedicine, Immunotherapy, and Hormone Therapy

New Horizons in Prostate Cancer Treatment: Nanomedicine, Immunotherapy, and Hormone Therapy Prostate cancer (PC) stands as the third most common malignancy among men worldwide, presenting a significant challenge due to its complex etiology and resistance to conventional treatments. The disease primarily arises from various genetic mutations that disrupt chromatin structure, leading to uncontrolled cellular proliferation. […]